Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis

Cancer Genetics and Cytogenetics

Volumn 93, Issue 1, 1997, Pages 56-62

  Miura, Norimasa ^a   Horikawa, Izumi ^a   Nishimoto, Arata ^a   Ohmura, Hiroshi ^a   Ito, Hisao ^b   Hirohashi, Setsuo ^c   Shay, Jerry W ^d   Oshimura, Mitsuo ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REACTIVATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; TELOMERE;

ADOLESCENT; ADULT; AGED; BLOTTING, SOUTHERN; CARCINOMA, HEPATOCELLULAR; ENZYME ACTIVATION; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TELOMERASE; TELOMERE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0031054261     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00329-9     Document Type: Article

References (40)

1. 1. Tsuda H, Hirohashi S. Shimosato Y, Ino Y, Yoshida T, Terada M (1989): Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res 80:196-199.
2. 2. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A. Govindarajah S (1989): Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852-8856.
3. 3. Zhang W, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T (1990): Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81:108-111.
4. 4. Murakami Y, Hayashi K, Hirohashi S, Sekiya T (1991): Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinoma. Cancer Res 51:5520-5525.
5. 5. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M. Nakamura Y (1992): Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52:5368-5372.
6. 6. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Sato C, Tsuruta K, Maeda Y, Koike M, Tanaka S, Nakamura Y, Hattori N. Miyaki M (1993): Genetic changes and histopathological grades in human hepatocellular carcinomas. Jpn J Cancer Res 84:893-899.
7. 7. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G (1995): Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet 9:41-47.
8. 8. Beasley RP, Hwang LY (1984): In: Viral Hepatitis, Liver Disease. GN Vyas, JL Dienstag, JH Hoofnagle, eds. Epidemiology of hepatocellular carcinoma. (Grune & Stratton, New York), pp. 209-224.
9. 9. Tiollais P, Pourcel C, Dejean A (1985): The hepatitis B virus. Nature 317:489-495.
10. 10. Robinson WS, Klote L, Aoki N (1990): Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J Med Virol 31:18-32.
11. 11. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G (1990): Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6547-6549.
12. 12. Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH (1990): Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus. EMBO J 9:1137-1145.
13. 13. Kim CM, Koike K, Saito I, Miyamura T, Jay G (1991): HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320.
14. 14. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH (1993): Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742-743.
15. n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85:6622-6626.
16. 16. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC (1990): Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868.
17. 17. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y (1992): Length of telomeric repeats in neuroblastoma: Correlation with prognosis and other biological characteristics. Jpn J Cancer Res 83:159-164.
18. 18. Nurnberg P, Thiel G, Weber F. Epplen ST (1993): Changes of telomere lengths in human intracranial tumours. Hum Genet 91:190-192.
19. 19. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K (1994): Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 54:3557-3560.
20. 20. Harley CB, Futcher AB, Greider CW (1990): Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460.
21. 21. Lindsey J. McGill N, Lindsey L, Green D, Cooke H (1991): In vivo loss of telomeric repeats with age in humans. Mutat Res 256:45-48.
22. 22. Allsopp RC, Vaziri C, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992): Telomere length predicts replicative capacity of human fibrohlasts. Proc Natl Acad Sci U S A 89:10114-10118.
23. 23. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB (1992): Telomere end-replication problem and cell ageing. J Mol Biol 225:951-960.
24. 24. Watson JD (1972): Origin of concatemeric T7 DNA. Nature 239:197-201.
25. 25. Morin GB (1989): The human telomere terminal transferase enzyme is a ribomicleoprotein that synthesizes TTAGGG repeats. Cell 59:521-529.
26. 26. Greider CW (1990): Telomeres, telomerase and senescence. Bioassays 12:363-369.
27. 27. Harley CB (1991): Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 256:271-282.
28. 28. Wright WE, Shay JW (1992): Telomere positional effects and the regulation of cellular senescence. Trends Genet 8:193-197.
29. 29. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992): Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929.
30. 30. Shay JW, Wright WE, Werbin H (1993): Loss of telomeric DNA during aging may predispose cells to cancer. Int J Oncol 3:559-563.
31. 31. Counter CM, Hirte HW, Bacchetti S, Harley CB (1994): Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 91:2900-2904.
32. 32. de Lange T (1994): Activation of telomerase in a human tumor. Proc Natl Acad Sci U S A 91:2882-2885.
33. 33. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994): Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
34. 34. Wright WE, Shay JW, Piatyszek M (1995): Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucl Acids Res 23:3794-3795.
35. 35. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S (1994): Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68:3410-3414.
36. 36. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS (1995): Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 15:425-432.
37. 37. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T (1995): Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55:2734-2736.
38. 38. Tsuda H, Hirohashi S, Shimosato Y, Terada M, Hasegawa H (1988): Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 95:1664-1666.
39. 39. Nakamura Y, Terada T, Ueda K, Terasaki S, Nonomura A, Matsui O (1993): Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 13:1-9.
40. 40. Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M (1992): Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology 15:843-848.